| 1 |
Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, Zhang Z, Yang S, Xiao M. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer 2023;22:48. [PMID: 36906534 DOI: 10.1186/s12943-023-01744-8] [Reference Citation Analysis]
|
| 2 |
Fang L, Tian W, Zhang C, Wang X, Li W, Zhang Q, Zhang Y, Zheng J. Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma. Pharmacol Res 2023;189:106701. [PMID: 36796464 DOI: 10.1016/j.phrs.2023.106701] [Reference Citation Analysis]
|
| 3 |
Tawfik HO, Belal A, Abourehab MAS, Angeli A, Bonardi A, Supuran CT, El-Hamamsy MH. Dependence on linkers' flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents. J Enzyme Inhib Med Chem 2022;37:2765-85. [PMID: 36210545 DOI: 10.1080/14756366.2022.2130285] [Reference Citation Analysis]
|
| 4 |
Baldari S, Di Modugno F, Nisticò P, Toietta G. Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy. Cancers 2022;14:4706. [DOI: 10.3390/cancers14194706] [Reference Citation Analysis]
|
| 5 |
Mcdonald PC, Chafe SC, Supuran CT, Dedhar S. Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. Cancers 2022;14:3297. [DOI: 10.3390/cancers14143297] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 6 |
Zhang Z, Li D, Yun H, Liu W, Chai K, Tong J, Zeng T, Gao Z, Xie Y. CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future. Front Oncol 2022;12:915171. [DOI: 10.3389/fonc.2022.915171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Manole B, Damian C, Giusca S, Caruntu ID, Porumb-andrese E, Lunca C, Dorneanu OS, Iancu LS, Ursu RG. The Influence of Oncogenic Viruses in Renal Carcinogenesis: Pros and Cons. Pathogens 2022;11:757. [DOI: 10.3390/pathogens11070757] [Reference Citation Analysis]
|
| 8 |
Luo Z, Yao X, Li M, Fang, Fei Y, Cheng Z, Xu Y, Zhu B. Modulating tumor physical microenvironment for fueling CAR-T cell therapy. Adv Drug Deliv Rev 2022;185:114301. [PMID: 35439570 DOI: 10.1016/j.addr.2022.114301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
|
